PL2400973T3 - Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka - Google Patents

Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka

Info

Publication number
PL2400973T3
PL2400973T3 PL10744058T PL10744058T PL2400973T3 PL 2400973 T3 PL2400973 T3 PL 2400973T3 PL 10744058 T PL10744058 T PL 10744058T PL 10744058 T PL10744058 T PL 10744058T PL 2400973 T3 PL2400973 T3 PL 2400973T3
Authority
PL
Poland
Prior art keywords
pten
identification
treat cancer
extracellular form
extracellular
Prior art date
Application number
PL10744058T
Other languages
English (en)
Inventor
Ramon Parsons
Original Assignee
The Trustees Of Columbia University In The City Of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Trustees Of Columbia University In The City Of New York filed Critical The Trustees Of Columbia University In The City Of New York
Publication of PL2400973T3 publication Critical patent/PL2400973T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL10744058T 2009-02-17 2010-02-17 Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka PL2400973T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20797409P 2009-02-17 2009-02-17

Publications (1)

Publication Number Publication Date
PL2400973T3 true PL2400973T3 (pl) 2017-09-29

Family

ID=42634379

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10744058T PL2400973T3 (pl) 2009-02-17 2010-02-17 Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka

Country Status (19)

Country Link
US (1) US9017981B2 (pl)
EP (1) EP2400973B1 (pl)
JP (2) JP5767117B2 (pl)
CN (1) CN102387810B (pl)
AU (2) AU2010216370A1 (pl)
BR (1) BRPI1005951A2 (pl)
CA (1) CA2752590C (pl)
CY (1) CY1118861T1 (pl)
DK (1) DK2400973T3 (pl)
ES (1) ES2623393T3 (pl)
HR (1) HRP20170306T1 (pl)
HU (1) HUE032028T2 (pl)
LT (1) LT2400973T (pl)
MX (1) MX2011008695A (pl)
PL (1) PL2400973T3 (pl)
PT (1) PT2400973T (pl)
SI (1) SI2400973T1 (pl)
SM (1) SMT201700159T1 (pl)
WO (1) WO2010096173A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011218037B2 (en) * 2010-02-17 2016-10-13 The Trustees Of Columbia University In The City Of New York Use of PTEN-long leader sequence for transmembrane delivery of molecules
WO2015105957A1 (en) 2014-01-08 2015-07-16 Shriners Hospitals For Children Pten antagonist peptides and methods of using the same
US20200085890A1 (en) * 2016-07-29 2020-03-19 Ohio State Innovation Foundation Expression of pten-long with ocolytic viruses
CN109022461B (zh) * 2017-06-08 2022-01-14 中山大学附属第一医院 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用
CN108504671A (zh) * 2018-03-28 2018-09-07 宁波市医疗中心李惠利医院 一种PTEN-Long蛋白纯化制备方法
CN112236131A (zh) 2018-03-29 2021-01-15 技术研究及发展基金有限公司 包含pten抑制剂的囊泡及其用途
CA3134665A1 (en) * 2019-04-12 2020-10-15 Therapten Biosciences Inc. Compositions and methods to manufacture tumor suppressor fusions
CA3149478A1 (en) * 2019-08-05 2021-02-11 Mesoblast International Sarl Cellular compositions comprising viral vectors and methods of treatment
CN112813046A (zh) * 2021-01-08 2021-05-18 北京大学 一种pten亚型蛋白及其应用
CN112877309B (zh) * 2021-02-19 2022-05-17 北京大学 一种N端延长型PTEN亚型PTENζ蛋白及其编码基因和应用
WO2024163335A2 (en) * 2023-01-30 2024-08-08 The Board Of Regents Of The University Of Texas System Pten gene therapy vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482795B1 (en) * 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
CA2410514A1 (en) * 2000-05-30 2001-12-06 Advanced Research & Technology Institute Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
WO2004093820A2 (en) * 2003-04-23 2004-11-04 University Of Massachusetts Methods and compositions for solid tumor treatment
CA2581423A1 (en) 2004-09-23 2006-03-30 Vasgene Therapeutics, Inc. Polipeptide compounds for inhibiting angiogenesis and tumor growth
AU2011218037B2 (en) 2010-02-17 2016-10-13 The Trustees Of Columbia University In The City Of New York Use of PTEN-long leader sequence for transmembrane delivery of molecules

Also Published As

Publication number Publication date
LT2400973T (lt) 2017-04-10
JP2015231372A (ja) 2015-12-24
HUE032028T2 (en) 2017-08-28
EP2400973A2 (en) 2012-01-04
PT2400973T (pt) 2017-03-07
AU2010216370A1 (en) 2011-09-22
EP2400973B1 (en) 2016-11-30
CA2752590C (en) 2017-08-22
BRPI1005951A2 (pt) 2016-10-11
HRP20170306T1 (hr) 2017-04-21
WO2010096173A2 (en) 2010-08-26
JP5973035B2 (ja) 2016-08-17
JP2012517827A (ja) 2012-08-09
SMT201700159T1 (it) 2017-05-08
CA2752590A1 (en) 2010-08-26
EP2400973A4 (en) 2013-02-27
US9017981B2 (en) 2015-04-28
JP5767117B2 (ja) 2015-08-19
DK2400973T3 (en) 2017-03-06
AU2016231517A1 (en) 2016-10-06
CN102387810B (zh) 2017-08-04
CY1118861T1 (el) 2018-01-10
US20120039861A1 (en) 2012-02-16
MX2011008695A (es) 2011-10-14
AU2016231517B2 (en) 2018-01-25
SI2400973T1 (sl) 2017-05-31
CN102387810A (zh) 2012-03-21
ES2623393T3 (es) 2017-07-11
WO2010096173A3 (en) 2010-10-21

Similar Documents

Publication Publication Date Title
IL289300A (en) Combination therapy for treating cancer
PL2400973T3 (pl) Identyfikacja zewnątrzkomórkowej postaci PTEN, która może być zastosowana do leczenia raka
CL2015001157A1 (es) Composiciones y métodos para tratar proteinopatías.
BR112012005594A2 (pt) tratamento de câncer
IL239007B (en) Eribulin for use in the treatment of breast cancer
LT2707030T (lt) Vėžio gydymas
PL2544682T3 (pl) Fitokannabinoidy w leczeniu glejaka
PT2897620T (pt) Método de tratamento de cancro
SMT201600050B (it) Mezzi e metodi per trattare il dlbcl
HUE047198T2 (hu) Fitokannabinoidok emlõrák kezelésére
HUE046667T2 (hu) Rák kombinatív kezelése
IL224370B (en) Combination treatment for prostate carcinoma
DK2646208T3 (da) Miljøvenlig træbehandlingsprocess
PL2630108T3 (pl) Sposób wytwarzania 2,3,3,3-tetrafluoropropenu
BR112014012880A2 (pt) tratamento imunogênico do câncer
PL2739153T3 (pl) Leczenie raka sutka
BR112012002797A2 (pt) tratamento de câncer de próstata
FR2955040B1 (fr) Pre-broyeur ou pre-dechiqueteur
BR112013011659A2 (pt) métodos de tratamento do câncer
HRP20170225T1 (hr) Fosfoplatini i njihova uporaba za liječenje karcinoma
PL2742356T3 (pl) Środki prognostyczne w leczeniu nowotworów
SI2892925T1 (sl) Kombinacijsko zdravljenje raka
FI20106078A0 (fi) Puukuitupitoisen jakeen käsittely
IL213919A0 (en) Methods to treat cancer
SMT201600367B (it) Indumento intimo